These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17310258)

  • 1. Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report.
    Saulino M
    Spinal Cord; 2007 Nov; 45(11):749-52. PubMed ID: 17310258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPIDOL study protocol for the assessment of intrathecal ziconotide antalgic efficacy for severe refractory neuropathic pain due to spinal cord lesions.
    Brinzeu A; Berthiller J; Perreton N; Subtil F; Gervaise C; Luaute J; Mertens P;
    Trials; 2024 Sep; 25(1):595. PubMed ID: 39244617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziconotide for spinal cord injury-related pain.
    Brinzeu A; Berthiller J; Caillet JB; Staquet H; Mertens P
    Eur J Pain; 2019 Oct; 23(9):1688-1700. PubMed ID: 31233255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziconotide Trialing by Intrathecal Bolus Injections: An Open-Label Non-Randomized Clinical Trial in Postoperative/Posttraumatic Neuropathic Pain Patients Refractory to Conventional Treatment.
    Bäckryd E; Sörensen J; Gerdle B
    Neuromodulation; 2015 Jul; 18(5):404-13. PubMed ID: 25879804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report.
    Horazeck C; Huh AS; Huh BK
    Pain Pract; 2015 Mar; 15(3):E34-9. PubMed ID: 25565390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ziconotide combination intrathecal therapy: rationale and evidence.
    Wallace MS; Rauck RL; Deer T
    Clin J Pain; 2010 Sep; 26(7):635-44. PubMed ID: 20639730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
    Wermeling DP; Berger JR
    Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal Ziconotide Infusion Therapy for Oncologic Refractory Neuropathic Pain: Case Report With High-Dose Intraventricular Ziconotide After 15 Years of Treatment.
    López-Millán JM; Coca-Gamito C
    Neuromodulation; 2024 Oct; 27(7):1251-1253. PubMed ID: 39078347
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziconotide intrathecal delivery as treatment for secondary therapeutic failure of motor cortex stimulation after 6 years.
    Voirin J; Darie I; Fischer D; Simon A; Rohmer-Heitz I; Proust F
    Neurochirurgie; 2016 Oct; 62(5):284-288. PubMed ID: 27771111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats.
    Roh DH; Yoon SY; Seo HS; Kang SY; Han HJ; Beitz AJ; Lee JH
    Exp Neurol; 2010 Jul; 224(1):123-32. PubMed ID: 20226782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing.
    Shao MM; Khazen O; Hellman A; Czerwinski M; Dentinger R; DiMarzio M; Gillogly M; Hadanny A; Argoff C; Pilitsis JG
    World Neurosurg; 2021 Jan; 145():e340-e347. PubMed ID: 33096281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
    Wallace MS
    Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal ziconotide for neuropathic pain: a review.
    Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
    Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.